The earnings call showcased strong operational performance, highlighted by a raised revenue guidance and positive feedback on new technologies. However, challenges remain with the decline in Dry Eye revenue and the ongoing difficulty in securing reimbursement for TearCare. Despite these issues, the company demonstrated effective management and strategic direction, particularly in the Surgical Glaucoma segment.

Company Guidance -

Q3 2025

During Sight Sciences' second quarter 2025 earnings call, the company raised its full-year revenue guidance to $72 million to $76 million, reflecting strong momentum in its Surgical Glaucoma segment. The second quarter revenue reached $19.6 million, driven by a 12% increase from the first quarter of 2025. The company reported a 4% sequential growth in ordering accounts and a 4% increase in surgical glaucoma utilization, despite a 5% year-over-year decline in Surgical Glaucoma revenue. Sight Sciences continues to focus on achieving reimbursement for its TearCare product, although Dry Eye revenue decreased to $0.3 million due to fewer SmartLids sales. Gross margin held steady at 85%, while adjusted operating expenses were reduced by 8% to $24.4 million. The company remains optimistic about its strategic initiatives, including the launch of OMNIEdge and expanding market access for TearCare, as it aims to strengthen its leadership in implant-free MIGS and develop the reimbursed procedural Dry Eye market.

Revenue Guidance Raised

Sight Sciences raised its full-year 2025 revenue guidance to $72 million to $76 million, up from the previous $70 million to $75 million.

Surgical Glaucoma Segment Growth

The Surgical Glaucoma segment saw a 12% increase in revenue compared to the first quarter of 2025, reaching $19.2 million.

OMNIEdge Positive Reception

The new OMNIEdge technology was well-received by surgeons, contributing to improvements in OMNI utilization.

Record High Ordering Accounts

Ordering accounts reached a record high, up 6% sequentially and 4% year-over-year.

Publication of SAHARA RCT Results

The 24-month results of the SAHARA RCT were published, demonstrating the durability of the TearCare procedure for treating dry eye disease.

Strong Gross Margin

The company maintained a gross margin of 85% for the quarter.

Sight Sciences (SGHT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

SGHT Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 06, 2025	2025 (Q3)	-0.25 / -	-0.22	―	―	―
Aug 07, 2025	2025 (Q2)	-0.26 / -0.23	-0.25	8.00% (+0.02)
May 08, 2025	2025 (Q1)	-0.28 / -0.28	-0.33	15.15% (+0.05)	―
Mar 05, 2025	2024 (Q4)	-0.20 / -0.23	-0.22	-4.55% (-0.01)
Nov 07, 2024	2024 (Q3)	-0.21 / -0.22	-0.27	18.52% (+0.05)
Aug 01, 2024	2024 (Q2)	-0.30 / -0.25	-0.3	16.67% (+0.05)
May 02, 2024	2024 (Q1)	-0.28 / -0.33	-0.35	5.71% (+0.02)
Mar 07, 2024	2023 (Q4)	-0.32 / -0.22	-0.35	37.14% (+0.13)	―
Nov 07, 2023	2023 (Q3)	-0.32 / -0.27	-0.46	41.30% (+0.19)	―
Aug 03, 2023	2023 (Q2)	-0.34 / -0.30	-0.5	40.00% (+0.20)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

SGHT Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 07, 2025	$3.55	$4.24	+19.44%
May 08, 2025	$3.03	$3.08	+1.65%
Mar 05, 2025	$2.42	$2.49	+2.89%
Nov 07, 2024	$4.68	$4.23	-9.62%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sight Sciences (SGHT) report earnings?

Sight Sciences (SGHT) is schdueled to report earning on Nov 06, 2025, After Close (Confirmed).

What is Sight Sciences (SGHT) earnings time?

Sight Sciences (SGHT) earnings time is at Nov 06, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is SGHT EPS forecast?

SGHT EPS forecast for the fiscal quarter 2025 (Q3) is -0.25.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing